Andon Health Co Ltd
SZSE:002432

Watchlist Manager
Andon Health Co Ltd Logo
Andon Health Co Ltd
SZSE:002432
Watchlist
Price: 73.5 CNY -2.21% Market Closed
Market Cap: ¥34.2B

EV/GP

24.2
Current
294%
More Expensive
vs 3-y average of 6.1

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
24.2
=
Enterprise Value
¥28.4B
/
Gross Profit
¥1B

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
24.2
=
Enterprise Value
¥28.4B
/
Gross Profit
¥1B

Valuation Scenarios

Andon Health Co Ltd is trading above its 3-year average

If EV/GP returns to its 3-Year Average (6.1), the stock would be worth ¥18.64 (75% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-82%
Maximum Upside
No Upside Scenarios
Average Downside
66%
Scenario EV/GP Value Implied Price Upside/Downside
Current Multiple 24.2 ¥73.5
0%
3-Year Average 6.1 ¥18.64
-75%
5-Year Average 4.3 ¥13.19
-82%
Industry Average 8.4 ¥25.49
-65%
Country Average 13.6 ¥41.21
-44%

Forward EV/GP
Today’s price vs future gross profit

Not enough data available to calculate forward EV/GP

Peer Comparison

All Multiples
EV/GP
P/E
All Countries
Close
Market Cap EV/GP P/E
CN
Andon Health Co Ltd
SZSE:002432
34.2B CNY 24.2 18.1
US
Intuitive Surgical Inc
NASDAQ:ISRG
162.6B USD 23.6 56.9
US
Abbott Laboratories
NYSE:ABT
155.4B USD 6.1 24.8
US
Stryker Corp
NYSE:SYK
112.7B USD 7.6 34.7
IE
Medtronic PLC
NYSE:MDT
102.7B USD 5.3 22.3
US
Boston Scientific Corp
NYSE:BSX
83.8B USD 6.5 23.5
US
Edwards Lifesciences Corp
NYSE:EW
48.8B USD 9.2 44.5
DE
Siemens Healthineers AG
XETRA:SHL
39.3B EUR 5.2 18.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.2B USD 17.1 42.7
US
Becton Dickinson and Co
NYSE:BDX
42.5B USD 5.8 24.2
US
Resmed Inc
NYSE:RMD
29.9B USD 8.8 20.1

Market Distribution

Higher than 71% of companies in China
Percentile
71st
Based on 6 967 companies
71st percentile
24.2
Low
0 — 8
Typical Range
8 — 23.3
High
23.3 —
Distribution Statistics
China
Min 0
30th Percentile 8
Median 13.6
70th Percentile 23.3
Max 17 898 541.1

Andon Health Co Ltd
Glance View

Market Cap
34.2B CNY
Industry
Health Care

In the dynamic realm of China's healthcare technology industry, Andon Health Co., Ltd. has carved out a distinctive niche as a pivotal player specializing in the development and manufacturing of medical devices. Founded in 1995 in the bustling city of Tianjin, Andon Health has evolved from its modest beginnings into a formidable enterprise, known primarily for its suite of health management products. These include blood pressure monitors, glucose meters, and other telemedicine devices designed to accommodate the rising demand for home healthcare solutions. By blending innovation with meticulous production techniques, Andon Health ensures that its devices not only meet rigorous safety standards but also address the growing need for accurate, easy-to-use health monitoring tools in both domestic and international markets. Central to Andon Health’s business model is its strategic engagement with both direct consumers and healthcare institutions through a robust distribution network and comprehensive digital platforms. The company generates revenue by selling its products through a mix of online platforms and traditional retail channels, while also engaging in partnerships with global healthcare providers who seek to integrate Andon’s technology into their patient care services. Moreover, Andon's commitment to research and development steers its constant product evolution, enhancing performance and expanding its market reach. Driven by an ethos of improving lives with technology, Andon Health adeptly navigates the confluence of healthcare needs and technological advances, positioning itself as a trusted name in households and hospitals alike, as it continues to pursue a trajectory of growth and influence within the global health industry.

Intrinsic Value
41.23 CNY
Overvaluation 44%
Intrinsic Value
Price ¥73.5
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett